CARDIOVASCULAR DRUGS
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
LISINOPRIL & HYDROCHLOROTHIAZIDE: products 1 to 18 of 18.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Lisinopril/HCTZ (Type Z) 10mg & 12.5mg TabDIN 02362945 | General benefit | $0.2084per source unit | Requirements & sourcesBuild cost plan |
| Lisinopril/HCTZ (Type Z) 20mg & 12.5mg TabDIN 02362953 | General benefit | $0.2504per source unit | Requirements & sourcesBuild cost plan |
| Lisinopril/HCTZ (Type Z) 20mg & 25mg TabDIN 02362961 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Prinzide 10mg & 12.5mg TabDIN 02108194 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Prinzide 20mg & 12.5mg TabDIN 00884413 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Prinzide 20mg/25mg TabDIN 00884421 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Sandoz Lisinopril HCT 10mg & 12.5mg TabDIN 02302365 | General benefit | $0.2084per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Lisinopril HCT 20mg & 12.5mg TabDIN 02302373 | General benefit | $0.2504per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Lisinopril HCT 20mg & 25mg TabDIN 02302381 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type P) 10mg & 12.5mg TabDIN 02302136 | General benefit | $0.3334per source unit | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type P) 20mg & 12.5mg TabDIN 02302144 | General benefit | $0.4006per source unit | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type P) 20mg/25mg TabDIN 02302152 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type Z) 10mg & 12.5mg TabDIN 02301768 | General benefit | $0.2084per source unit | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type Z) 20mg & 12.5mg TabDIN 02301776 | General benefit | $0.2504per source unit | Requirements & sourcesBuild cost plan |
| Teva-Lisinopril/HCTZ (Type Z) 20mg & 25mg TabDIN 02301784 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Zestoretic 10mg & 12.5mg TabDIN 02103729 | General benefit | $0.2084per source unit | Requirements & sourcesBuild cost plan |
| Zestoretic 20mg & 12.5mg TabDIN 02045737 | General benefit | $0.2504per source unit | Requirements & sourcesBuild cost plan |
| Zestoretic 20mg & 25mg TabDIN 02045729 | Off-Formulary Interchangeable, not an ODB benefit | No price in this record | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
24:00 CARDIOVASCULAR DRUGS.
24:04 Cardiac Drugs.
24:06 Antilipemic Drugs.
24:06:24 PCSK9 Inhibitors.
24:08 Hypotensive Drugs (For Diuretics See 40:28).
24:08:16 Central Alpha-Agonists.
24:12 Vasodilating Drugs.
24:32:08 Angiotensin II Receptor Antagonists.